ATE259240T1 - Serumzusammensetzungen zur hemmung von retroviren und tumorwachstum - Google Patents
Serumzusammensetzungen zur hemmung von retroviren und tumorwachstumInfo
- Publication number
- ATE259240T1 ATE259240T1 AT96920129T AT96920129T ATE259240T1 AT E259240 T1 ATE259240 T1 AT E259240T1 AT 96920129 T AT96920129 T AT 96920129T AT 96920129 T AT96920129 T AT 96920129T AT E259240 T1 ATE259240 T1 AT E259240T1
- Authority
- AT
- Austria
- Prior art keywords
- serum
- inhibiting
- tumor growth
- serum compositions
- compositions
- Prior art date
Links
- 210000002966 serum Anatomy 0.000 title abstract 4
- 230000002401 inhibitory effect Effects 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000004614 tumor growth Effects 0.000 title abstract 2
- 108060003951 Immunoglobulin Proteins 0.000 abstract 2
- 102000018358 immunoglobulin Human genes 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 241000251730 Chondrichthyes Species 0.000 abstract 1
- 206010038997 Retroviral infections Diseases 0.000 abstract 1
- 206010039491 Sarcoma Diseases 0.000 abstract 1
- 102000005686 Serum Globulins Human genes 0.000 abstract 1
- 108010045362 Serum Globulins Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940072221 immunoglobulins Drugs 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
- 241001430294 unidentified retrovirus Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43443895A | 1995-05-03 | 1995-05-03 | |
| US513395P | 1995-10-10 | 1995-10-10 | |
| PCT/US1996/006245 WO1996034616A1 (en) | 1995-05-03 | 1996-05-03 | Serum preparations for inhibiting retroviruses and tumor growth |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE259240T1 true ATE259240T1 (de) | 2004-02-15 |
Family
ID=26673973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96920129T ATE259240T1 (de) | 1995-05-03 | 1996-05-03 | Serumzusammensetzungen zur hemmung von retroviren und tumorwachstum |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0835124B1 (de) |
| JP (1) | JPH11504636A (de) |
| KR (1) | KR19990008226A (de) |
| AT (1) | ATE259240T1 (de) |
| AU (1) | AU696602B2 (de) |
| CA (1) | CA2219899A1 (de) |
| DE (1) | DE69631528T2 (de) |
| WO (1) | WO1996034616A1 (de) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2019180C1 (ru) * | 1993-01-12 | 1994-09-15 | Яков Давидович Безман | Средство для лечения подкожной фибросаркомы и способ его получения |
-
1996
- 1996-05-03 JP JP8533532A patent/JPH11504636A/ja not_active Ceased
- 1996-05-03 AU AU58529/96A patent/AU696602B2/en not_active Ceased
- 1996-05-03 AT AT96920129T patent/ATE259240T1/de not_active IP Right Cessation
- 1996-05-03 WO PCT/US1996/006245 patent/WO1996034616A1/en active IP Right Grant
- 1996-05-03 DE DE69631528T patent/DE69631528T2/de not_active Expired - Fee Related
- 1996-05-03 CA CA002219899A patent/CA2219899A1/en not_active Abandoned
- 1996-05-03 KR KR1019970707752A patent/KR19990008226A/ko not_active Application Discontinuation
- 1996-05-03 EP EP96920129A patent/EP0835124B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69631528T2 (de) | 2004-12-16 |
| AU696602B2 (en) | 1998-09-17 |
| DE69631528D1 (de) | 2004-03-18 |
| WO1996034616A1 (en) | 1996-11-07 |
| JPH11504636A (ja) | 1999-04-27 |
| EP0835124A4 (de) | 2000-11-02 |
| AU5852996A (en) | 1996-11-21 |
| EP0835124A1 (de) | 1998-04-15 |
| EP0835124B1 (de) | 2004-02-11 |
| KR19990008226A (ko) | 1999-01-25 |
| CA2219899A1 (en) | 1996-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3853779D1 (de) | Hiv-1 neutralisierende monoklonale antikörper. | |
| DE69838986D1 (de) | Polypeptide, deren herstellung und verwendung | |
| EP0158277A3 (de) | Implantierbare Zubereitungen von regulatorischen Peptiden mit gesteuerter Freisetzung und Verfahren zur ihrer Herstellung | |
| ATE242633T1 (de) | Dialkylfumarate zur behandlung von autoimmunerkrankungen | |
| DE3887014D1 (de) | Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen. | |
| ATE54826T1 (de) | Thymusextraktfraktionen enthaltende pharmazeutische zusammensetzung. | |
| ATE165345T1 (de) | Sulfonsaeurederivate zur behandlung von viruserkrankungen | |
| DE3780016D1 (de) | Pharmazeutisches praeparat mit 3'-desoxythymidin-2'-en(3'-desoxy-2',3'-didehydrothymidin) zur behandlung von patienten mit retroviralen infektionen. | |
| ES2043609T3 (es) | Composiciones de interleucina-2. | |
| DE58909850D1 (de) | Arzneimittel zur behandlung von krebs, aids und viruserkrankungen | |
| DE69227500T2 (de) | In der Therapie von einer HIV-1-Infektion verwendbare monoklonale Antikörper | |
| DE3781652T2 (de) | Zubereitung, geeignet fuer die behandlung von darmstoerungen. | |
| ATE259240T1 (de) | Serumzusammensetzungen zur hemmung von retroviren und tumorwachstum | |
| ATE168698T1 (de) | Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten | |
| ATE63904T1 (de) | Azolderivate, geeignet zur bekaempfung von pflanzen-krankheiten. | |
| DE3687233T2 (de) | Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten. | |
| DE3874606D1 (de) | Behandlung von viraler infektion. | |
| DE59107240D1 (de) | Emulgatorfreie Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe und ihre Herstellung | |
| FI890907A0 (fi) | Kymotrypsiinin käyttö prekallikreiini-aktivaattorin tehottamiseksi tekemiseksi | |
| ATE108832T1 (de) | Verwendung von monoklonalen antikörpern gegen b2- mikroglobulin. | |
| ATE121935T1 (de) | D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren. | |
| ATE86863T1 (de) | Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen. | |
| DE3784891T2 (de) | Verfahren zur Isolierung von säurestabilen, biologisch aktiven Proteinen. | |
| ATE63457T1 (de) | Arzneimittel zur behandlung und prophylaxe von leber- und nierenkrankheiten. | |
| ATE74004T1 (de) | Mischung zur behandlung von hypercholesterolemie. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |